Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006:63 Suppl 3:156-8.

[Calpain-calpastatin system in erythrocytes of children with chronic renal failure]

[Article in Polish]
Affiliations
  • PMID: 16898518

[Calpain-calpastatin system in erythrocytes of children with chronic renal failure]

[Article in Polish]
Dorota Polak-Jonkisz et al. Przegl Lek. 2006.

Abstract

Introduction: Disturbances of erythrocyte calcium homeostasis in the course of chronic renal failure (CRF) may result from impaired function of a membrane calcium pump (PMCA). Plasma membrane Ca+2-transport ATP-ase is responsible for maintaining cytoplasmic level of intracellular Ca+2. PMCA activity is regulated by high Ca levels and calmodulin, in case of Ca+2 deficiency--by intracellular cysteine protease--calpain, and its natural inhibitor--calpastatin. The aim of the study was to assess the relationship between the activity of PMCA and calpain-calpastatin system in erythrocytes of children with CRF treated conservatively.

Material and methods: The study was performed on 21 CRF children treated conservatively (gr. I) aged 6-18 years. The control group consisted of 18 healthy age matched children. The parameters evaluated in erythrocytes were as follows: calpain-calpastatin system (Cp-Cs) activity, PMCA activity, level of intracellular Ca (Cai+2) and calmodulin (Ca) activity.

Results: Our investigation revealed: calmodulin concentrations decrement in CRF children (2.08 +/- 0.51 mg/L) vs. controls (4.54 +/- 1.09 nmol/min/mg) (p<0.01), calpain activity in CRF children (60.56 +/- 12.43 U/mg) higher than in controls (45.34 +/- 5.65 U/mg) (p<0.01) and calpastatin activity increment in gr. I (40.03 +/- 10.24 U/mg) vs. control group (20.123.05 U/mg) (p<0.01). Decreased activity of a system containing an enzyme and its inhibitor (calpain-calpastatin) was also observed: 1 : 0.66 ratio in gr. I vs 1:0.4 ratio in controls.

Conclusions: There is a decrease inPMCA activity and an increase of intracellular calcium in erythrocytes of children with mild CRF. The concomitant increment of erythrocyte calpastatin is the cause of disturbances in calpain-calpastatin system, thus unabling normalization of PMCA pump activity.

PubMed Disclaimer

Similar articles

Publication types

LinkOut - more resources